Meningeal Carcinomatosis - 25 Studies Found
Terminated |
: Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine :
: 2003-12-16 : Drug: Gemcitabine Schedule |
Terminated |
: A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer :
: 2009-01-24 : Drug: Erlotinib Erlotinib 150mg/day |
Recruiting |
: A Prospective, Observational Trial on the Diagnostic and Prognostic of LM :
: 2015-11-16 |
Completed |
: Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis. :
: 2009-03-02 :
|
Completed |
: DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor : Meningeal Neoplasms : 2002-01-15 :
|
Withdrawn |
: A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis : Lymphoma, B Cell : 2005-09-13 : Drug: intrathecal rituximab |
Withdrawn |
: High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations : Non-Small Cell Lung Cancer : 2006-09-06 : Drug: Gefitinib On days 1-14 gefitinib will be taken orally daily at either 750, 1000, or 1250mg (depend |
Completed |
: Melphalan in Patients With Neoplastic Meningitis :
|
Recruiting |
: Ipilimumab and Nivolumab in Leptomeningeal Metastases From Melanoma :
: 2016-08-29 :
|